CATEGORY:
Clinical Trials
TITLE:
FX-322 in Sensorineural Hearing Loss
INTERVENTION/TREATMENT:
PHASE:
DESCRIPTION:
Condition : Sensorineural Hearing Loss
Interventions : Drug: FX-322; Drug: Placebo
Sponsor : Frequency Therapeutics
Completed
ID:
NCT03616223
STATUS:
DATE – FIRST POSTED:
Mon, 06 Aug 2018 12:00:00 EDT
DATE – LAST UPDATE POSTED:
03/30/21 06:51AM
DATE – RETRIEVED:
03/30/21 06:51AM
LINK – STUDY HISTORY:
https://clinicaltrials.gov/ct2/history/NCT03616223
LINK – STUDY RECORD:
https://clinicaltrials.gov/ct2/show/NCT03616223